by Plus Therapeutics | May 3, 2024 | Uncategorized
Reminder to come stop by the Plus Therapeutics booth #1057 at the American Association of Neurological Surgeons (AANS) annual conference this weekend in Chicago! Our team will be in the exhibit hall during the entire conference, so come say hello 👋 Home #AANS2024...
by Plus Therapeutics | May 1, 2024 | Uncategorized
Brain tumor research is at the heart of what we do. Our team focuses every day on how to fight for a cure, and we are passionate about the Brain Cancer community. 🧠🎗️ We have some great education events and news this month that we look forward to sharing with you all,...
by Plus Therapeutics | Apr 26, 2024 | Uncategorized
Come join us at the American Association of Neurological Surgeons (AANS) Annual Meeting in Chicago, IL next week! Visit our booth to learn about our #clinicaltrials for #patients with recurrent #glioblastoma, leptomeningeal #metastases, & pediatric #braincancer...
by Plus Therapeutics | Apr 25, 2024 | Uncategorized
“Plus Therapeutics’ commitment to revolutionizing cancer treatment extends beyond this latest award. With $23 million in active awards support, the company is at the forefront of targeted radiotherapeutic research. Moreover, ongoing trials, including...
by Plus Therapeutics | Apr 18, 2024 | Uncategorized
Join some of the Plus Therapeutics team at the Head for the Cure 5K – North Texas on May 4th! They will be out supporting the local community, cancer research, and “Defeating Brain Cancer Step by Step.” We hope to see you there 🏃🏃♂️🏃♀️ Event...
by Plus Therapeutics | Apr 15, 2024 | Uncategorized
#ICYMI: Plus Therapeutics added Dr. Andrew Brenner to our management team. Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory. Full Press...
Recent Comments